Lincoln Pharmaceuticals Limited has informed the Exchange about Appointment of Mr. Raja Karunanidhi Nagarajan as Senior General Manager- Research & Development (Designated as Senior Management Personnel ) of the Company with effect from 29th August, 2025.
LINCOLN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lincoln Pharmaceuticals has appointed Mr. Raja Karunanidhi Nagarajan as Senior General Manager - Research & Development, designated as Senior Management Personnel, effective August 29, 2025. Mr. Nagarajan brings over 20 years of experience in pharmaceutical R&D, particularly in formulation and process development of generic products for regulated US and EU markets. He has previously worked with Torrent Research Center, Lupin Limited, and Cadila Pharmaceuticals Limited. The appointment is permanent in nature with no fixed term mentioned.
This is a routine senior management hire that strengthens the company's R&D capabilities in generic formulations for international markets, which could support future product pipeline and exports. No material impact on stock price is expected from this disclosure alone.